In healthy muscle, HGF sits dormant within the supportive niche around muscle fibers. When tissue is damaged or mechanically stimulated, HGF is released and binds to c-Met receptors on satellite cells, the resident stem cells that restart proliferation and differentiation to rebuild muscle.

But aging appears to sabotage this repair pathway through a specific chemical modification: nitration. In prior work, scientists showed that nitro groups are added to two HGF sites (Y198 and Y250), disabling HGF’s ability to dock with c-Met—like a key that no longer fits its lock—thereby undermining regeneration.

Seeking a way to preserve HGF function rather than merely boost its levels, the team hypothesized that strong antioxidant chemistry might protect HGF from nitration or counteract the loss that nitration causes. They tested two sulfur-based trisulfide compounds known for redox activity: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS).

Laboratory results showed both compounds could suppress HGF nitration at Y198 and Y250. Yet c-Met binding was not fully restored, prompting the researchers to adjust the molar ratio of HGF to trisulfide from 1:4000 to 1:8000.

At the higher ratio, HGF’s c-Met binding affinity rose by more than two-fold, and nitration-related dysfunction—especially at Y198—became more resistant. The standout effect came from LASSS alone; GSSSG did not reproduce the same enhancement.

The researchers suggest LASSS may do more than scavenge reactive molecules: it may directly interact with HGF, inducing a subtle structural shift that yields an “enhanced” super-functional form capable of stronger receptor engagement and greater nitration tolerance.

To probe whether this translates in living tissue, the team used a mouse model of muscle atrophy induced by tail suspension. Mice pretreated with LASSS showed markedly reduced HGF nitration compared with untreated controls, confirming LASSS’s protective activity beyond cell experiments.

Further aging studies are needed to confirm effectiveness and safety in vivo, but the findings point toward a viral-science-ready concept: a single targeted chemistry change that keeps muscle repair signals working longer.

Subject of Research:
Not applicable

Article Title:
Enhanced HGF with increased receptor affinity and nitration-dysfunction resistance through interaction with lipoic acid trisulfide

News Publication Date:
24-Jul-2026

Web References:
http://dx.doi.org/10.1038/s41598-026-60835-w

References:
10.1038/s41598-026-60835-w

Image Credits:
Kyushu University

Keywords:
aging muscle, HGF, c-Met, satellite cells, nitration, trisulfide, lipoic acid trisulfide, LASSS, muscle atrophy, regenerative medicine

Colorectal cancer remains one of the leading malignancies afflicting older adults globally, with its incidence sharply increasing with age. The elderly demographic presents a unique challenge, as comorbidities and physiological decline complicate treatment protocols and recovery trajectories. Muscle wasting disorders like presarcopenia emerge as critical considerations, influencing not only physical frailty but also immune competence and metabolic homeostasis. The study’s meticulous approach to categorizing elderly colorectal cancer patients based on muscle mass metrics offers a refined lens through which clinicians can assess risks and customize care.

Presarcopenia, often underdiagnosed, precedes more debilitating sarcopenia and is characterized by a clinically significant reduction in appendicular skeletal muscle mass without the profound impact on muscle function seen in later stages. Its insidious onset often escapes routine clinical detection, yet its implications for cancer patients are profound. The research team employed advanced bioimpedance analysis and imaging techniques to quantify muscle mass accurately, enabling a stratified analysis of patient outcomes that accounted for the subtle gradations within sarcopenic syndromes.

Importantly, this study draws upon a robust dataset amassed from a single, high-volume medical institution, ensuring consistency in diagnostic criteria and treatment modalities. Retrospective cohort designs, while inherently observational, provide invaluable longitudinal data, capturing the evolution of cancer outcomes over extended periods. The researchers tracked survival rates, recurrence intervals, and complication frequencies, correlating these with presarcopenia status to map out a comprehensive prognostic landscape.

Findings from the study illuminate a stark reality: elderly colorectal cancer patients identified with presarcopenia exhibited significantly worse long-term survival compared to their counterparts with preserved muscle mass. This association persisted even after adjusting for confounders such as tumor stage, treatment regimen, and comorbid conditions. The hazard ratios underscored presarcopenia as an independent prognostic factor, pointing toward muscle preservation as a potential target for intervention.

The mechanistic underpinnings of this relationship are multifaceted. Skeletal muscle plays a crucial role beyond locomotion, serving as an endocrine organ that modulates systemic inflammation and energy metabolism. In presarcopenic states, the diminished muscle-derived cytokines, such as myokines, may impair the body’s immune surveillance and response to tumorigenesis. Moreover, muscle wasting exacerbates metabolic dysregulation, fostering a milieu conducive to cancer progression and therapy resistance.

This research also challenges existing paradigms regarding surgical and chemotherapeutic tolerance in aging patients. Traditionally, chronological age has heavily influenced treatment decisions; however, the study proposes muscle mass assessment as a superior biomarker to physiological age. Integrating presarcopenia evaluation into preoperative and pre-chemotherapy assessments could refine patient stratification, minimizing adverse events and optimizing outcomes.

From a clinical perspective, the implementation of targeted nutrition and resistance training regimens emerges as a compelling adjunctive strategy. Early identification of presarcopenic patients affords a therapeutic window to halt or reverse muscle loss, potentially enhancing resilience to cancer treatments. The study advocates for multidisciplinary care teams incorporating physical therapists, dietitians, and geriatricians to holistically address the complex needs of elderly colorectal cancer patients.

The implications extend beyond colorectal cancer, positing presarcopenia as a universal biomarker of vulnerability in oncology. Its detection could reshape screening programs, prompting preemptive interventions in various geriatric malignancies. Furthermore, pharmacological advancements aimed at anabolic pathways and mitochondrial function might complement existing regimens, mitigating sarcopenic progression and improving survival metrics.

As the population ages globally, the burden of cancer in the elderly intensifies, demanding innovations that reconcile oncological efficacy with quality of life preservation. This study’s insights underscore an urgent need for personalized medicine frameworks that transcend tumor-centric approaches. By foregrounding muscle health as a determinant of patient fate, the research catalyzes a paradigm shift emphasizing systemic vitality as integral to cancer care.

While the retrospective design limits causal inference, the rigorous methodology and statistically significant findings warrant prospective trials to validate interventional strategies targeting presarcopenia. Future research directions include exploring molecular biomarkers predictive of muscle degradation and elucidation of the bidirectional communication pathways between tumors and muscle tissue, aiming to unravel novel therapeutic targets.

Importantly, this study contributes to the evolving discourse on geriatric assessment tools, advocating for the inclusion of muscle mass evaluation alongside cognitive and functional measures. Such comprehensive profiling aligns with the burgeoning field of geriatric oncology, enhancing the precision of prognosis and therapy customization.

Moreover, the study’s focus on elderly patients captures a demographic often underrepresented in clinical trials, addressing a critical gap in evidence-based medicine. By illuminating heterogeneity within the elderly colorectal cancer population, it challenges the “one-size-fits-all” treatment approach, paving the way for stratified management protocols.

In conclusion, the work by Lee and colleagues represents a seminal contribution to understanding how presarcopenia shapes the trajectory of colorectal cancer in elderly patients. Beyond statistical associations, it envisions a future where muscle health is a pivotal axis in cancer management, ultimately improving longevity and life quality. This revelation is poised to resonate widely within oncology circles, sparking renewed interest in sarcopenia research and holistic geriatric care.

Subject of Research: Long-term outcomes in elderly colorectal cancer patients with presarcopenia.

Article Title: Long-term outcomes in elderly colorectal cancer patients with presarcopenia: a single center retrospective cohort study.

Article References:
Lee, Ky., Lee, J. & Oh, S.T. Long-term outcomes in elderly colorectal cancer patients with presarcopenia: a single center retrospective cohort study. BMC Geriatr (2026). https://doi.org/10.1186/s12877-026-06995-w

Image Credits: AI Generated

Skeletal muscle, a tissue essential for mobility and systemic metabolism, exhibits a well-documented decline in function and mass known as sarcopenia in the elderly. Despite extensive research, the precise molecular triggers driving this degeneration have remained elusive. The current study situates CMA, a specialized form of autophagy that selectively degrades cytosolic proteins bearing a KFERQ-like motif, as a central player in maintaining muscle proteostasis. CMA’s involvement in muscle health, until now, was poorly understood, and this research elucidates how its diminution with age leads to pathological consequences.

The authors utilized an array of cutting-edge techniques, including genetic mouse models with muscle-specific knockdowns of CMA components, longitudinal studies of muscle aging, and advanced proteomic profiling. These approaches demonstrated a striking inverse correlation between CMA activity and muscle pathology: as CMA efficiency waned with increasing age, hallmark features of muscle atrophy and fibrosis emerged. Specifically, the decline in lysosomal receptor LAMP-2A, a crucial facilitator of CMA, was linked to the buildup of damaged proteins and organelles that disrupt intracellular homeostasis.

Importantly, the study delineates the mechanistic cascade by which CMA impairment contributes to myopathy. Loss of CMA function led to the accumulation of oxidatively damaged and misfolded proteins, overwhelming other proteostasis mechanisms such as the ubiquitin-proteasome system and macroautophagy. This proteotoxic stress triggered maladaptive responses including endoplasmic reticulum stress and mitochondrial dysfunction, both well-established contributors to muscle degeneration. This comprehensive molecular interplay highlights CMA as a pivotal quality control gatekeeper whose failure precipitates cellular breakdown.

Furthermore, the study explored how pharmacological and genetic activation of CMA could mitigate muscle pathology in aged mice. Treatment with CMA enhancers restored proteostasis, ameliorated features of muscle atrophy, and improved muscle strength and endurance. These findings are particularly exciting as they suggest that CMA modulation could serve as a tangible therapeutic strategy to slow or reverse sarcopenic progression, moving beyond symptomatic treatment to disease modification.

Intriguingly, the research also suggests a feedback mechanism where declining CMA disrupts key signaling pathways involved in muscle regeneration and repair. For instance, the nuclear factor erythroid 2–related factor 2 (NRF2) pathway, critical for oxidative stress responses, was found to be dysregulated when CMA activity diminished. This crosstalk underscores the broader impact of CMA beyond protein degradation, indicating its role in maintaining cellular signaling equilibrium vital for muscle homeostasis.

Moreover, the implications of this work extend beyond skeletal muscle, potentially shedding light on systemic aging processes. Given CMA’s role in other tissues, its age-related decline may contribute to multifaceted frailty syndromes, involving the nervous system, heart, and liver. This systemic perspective positions CMA as a universal regulator of cellular longevity and integrity, with muscle serving as a powerful model to unravel its complex biology.

The research team conducted meticulous histological analyses to correlate cellular and tissue-level changes with molecular findings. Muscle biopsies from aged mice showed increased fibrosis and inflammation, correlating with CMA suppression. These structural deteriorations paralleled reductions in muscle fiber cross-sectional area and slowed contractile kinetics, firmly establishing the physiological consequences of CMA decline. Such multimodal characterizations reinforce the translational significance of the findings in human muscle aging.

An additional highlight of the study is the specification of CMA’s substrate repertoire relevant to muscle health. The proteomic analysis identified critical cytosolic proteins involved in mitochondrial biogenesis, antioxidant defense, and metabolic regulation as preferential CMA targets. The failure to clear dysfunctional variants of these proteins through compromised CMA resulted in metabolic inflexibility and heightened oxidative damage within muscle fibers, promoting atrophy and myopathy.

Critically, the authors discuss how the interplay between CMA and other autophagic pathways evolves with age. Their data illustrate a compensatory relationship whereby macroautophagy initially offsets CMA reduction but eventually succumbs to exhaustion. This temporal dynamic emphasizes the unique and non-redundant role of CMA in maintaining muscle proteostasis and spotlights the vulnerability introduced by its decline.

Beyond fundamental biology, the study proposes translational avenues, including the development of CMA-activating small molecules. The identification of such agents holds promise not only for sarcopenia but also for a spectrum of age-related diseases characterized by proteostasis imbalance. The authors advocate for further clinical evaluation of CMA modulators, envisioning a new class of interventions that bolster cellular quality control mechanisms to combat muscle aging and systemic decline.

In conclusion, this seminal research articulates a detailed mechanistic framework linking age-dependent CMA deterioration with skeletal muscle vulnerability and progressive myopathy. By establishing CMA as a linchpin in muscle health and aging, it profoundly expands our understanding of autophagy’s selective roles and their implications for organismal aging. The study sets a foundation for innovative therapeutic strategies aimed at restoring CMA function to preserve muscle integrity and improve quality of life in aging populations.

The implications of these findings are immense, especially considering the global demographic shift towards an aging society. Sarcopenia significantly impacts morbidity and mortality in the elderly, with limited treatment options currently available. By identifying CMA as a modifiable molecular determinant, this research inspires hope for effective interventions that can reverse or prevent debilitating muscle weakness.

Looking ahead, future research will need to explore the regulation of CMA during aging in humans and investigate how lifestyle factors such as diet, exercise, and pharmacological agents interface with this pathway. Furthermore, understanding the crosstalk between CMA and systemic inflammatory processes may illuminate the broader context of aging and age-related diseases, potentially unlocking integrated approaches for healthy aging.

This study not only deepens the molecular understanding of muscle aging but also highlights the power of targeted autophagy pathways in cellular maintenance. CMA emerges as a vital guardian of muscle proteostasis, whose safeguarding could transform the landscape of aging research and therapeutic innovation. As the field advances, harnessing the potential of CMA may revolutionize how we approach aging-associated muscle degeneration and improve longevity with maintained vitality.

Subject of Research:
The study investigates the role of chaperone-mediated autophagy (CMA) in the age-related decline of skeletal muscle function and its contribution to progressive myopathy.

Article Title:
Age-related decline of chaperone-mediated autophagy in skeletal muscle leads to progressive myopathy

Article References:
Santiago-Fernández, O., Coletto, L., Tasset, I. et al. Age-related decline of chaperone-mediated autophagy in skeletal muscle leads to progressive myopathy. Nat Metab (2025). https://doi.org/10.1038/s42255-025-01412-9

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-025-01412-9

Age-associated declines in muscle mass and bone density are primary contributors to increased fall risk, fractures, and subsequent disability in the elderly. Physical exercise, particularly endurance modalities, remains the cornerstone of musculoskeletal health maintenance; however, adherence and capacity diminish with advancing age. The study led by Julian A. Vallejo and Michael J. Wacker at the University of Missouri delves into leveraging endogenous exercise-induced molecules to amplify the benefits of physical activity, thereby addressing the pressing need for adjunctive interventions that can mimic or augment exercise effects.

L-β-aminoisobutyric acid, a myokine-like metabolite released during muscular activity, has garnered attention for its roles in modulating energy metabolism and promoting anabolic pathways in muscle and bone tissues. The research focused on middle-aged (12-month-old) C57BL6 male mice subjected to four treatment modalities over a three-month period: sedentary controls, voluntary wheel running (VWR), L-BAIBA supplementation alone, and a combined protocol of VWR plus L-BAIBA at a dose of 100 mg/kg/day. This stratified design allowed precise interrogation of the synergistic effects of exercise and the metabolite.

Histological analyses revealed that soleus muscle, predominantly comprising slow-twitch oxidative fibers critical for endurance and postural stability, exhibited pronounced hypertrophic and compositional shifts exclusively in the combined treatment group. This muscle group demonstrated increased fiber cross-sectional area, enhanced oxidative fiber number, and a shift toward a fatigue-resistant phenotype. These findings illustrate that L-BAIBA potentiates the adaptive plasticity of skeletal muscle to endurance exercise stimuli, likely through metabolic signaling cascades that remain to be fully elucidated.

Parallel assessments of the extensor digitorum longus (EDL) muscle, rich in fast-twitch fibers, showed no statistically significant alterations in total fiber number or cross-sectional area across cohorts, highlighting the selective muscle-type responsiveness to the intervention. This observation supports the notion that L-BAIBA and endurance exercise interactions preferentially target oxidative muscle phenotypes, critical for sustained locomotion and balance in aging subjects.

Bone morphology and density assessments further corroborated the dual benefits of L-BAIBA and exercise synergy. Trabecular bone thickness and volumetric density markedly increased in the VWR+L-BAIBA cohort, accompanied by a notable reduction in bone marrow adiposity, a deleterious factor linked to compromised bone regeneration and systemic metabolic dysfunction. These bone-centric adaptations reinforce the concept that muscle-derived metabolites can exert osteotropic effects, fostering a muscle-bone crosstalk axis essential for skeletal homeostasis during aging.

Despite minor modulations in cardiac electrical activity observed via electrocardiograms, L-BAIBA supplementation did not induce any adverse cardiac hypertrophy or functional impairment. This safety profile is imperative for considering translation to human applications, where cardiovascular health is paramount in aging populations engaging in exercise adjunct therapies.

Mechanistically, the potentiation of musculoskeletal health by L-BAIBA may involve pathways regulating mitochondrial biogenesis, reactive oxygen species scavenging, and modulation of local and systemic inflammatory milieus. By enhancing muscle oxidative capacity and bone remodeling, L-BAIBA emerges as a promising endogenous molecule capable of mimicking exercise-like benefits, a major advance for individuals facing physical limitations.

The utilization of voluntary wheel running as an exercise paradigm reflects clinically relevant endurance activity, mimicking naturalistic voluntary physical engagement rather than forced exertion. This methodological choice strengthens the relevance of findings and suggests that even modest, self-paced exercise, when coupled with metabolic supplementation, can yield substantial health dividends.

These results hold broad translational potential in gerontology and musculoskeletal medicine. Therapeutics combining metabolic mediators like L-BAIBA with prescribed physical activity regimens might counteract sarcopenia and osteoporosis, curtailing the morbidity associated with musculoskeletal frailty. Notably, the exclusive benefit from the combination therapy underscores the inadequacy of supplementation or exercise alone, advocating for integrated intervention frameworks.

The findings catalyze renewed interest in the muscle-bone endocrine axis, emphasizing myokines and exercise metabolites as critical modulators of tissue crosstalk and systemic aging phenotypes. Further investigations are warranted to dissect molecular signaling networks, optimize dosing strategies, and validate efficacy in diverse animal models and eventually human cohorts.

As populations worldwide confront the challenges of aging demographics, interventions that harness natural, exercise-induced compounds represent a paradigm shift. They bear the promise of extending functional independence and reducing healthcare burdens associated with musculoskeletal deterioration. This study lays foundational groundwork for harnessing the synergy between endogenous exercise metabolites and physical activity to foster musculoskeletal resilience in aging.

In summary, the integrative application of L-β-aminoisobutyric acid and voluntary endurance exercise demonstrates a significant enhancement of musculoskeletal properties in middle-aged male mice. These findings illuminate a novel therapeutic avenue that capitalizes on innate metabolic substances produced by exercise, offering a pragmatic and biologically harmonious strategy to mitigate the deleterious consequences of aging on muscle and bone health.

—
Subject of Research: Animals
Article Title: L-β-aminoisobutyric acid (L-BAIBA) in combination with voluntary wheel running exercise enhances musculoskeletal properties in middle-age male mice
News Publication Date: 1-Oct-2025
Web References: http://dx.doi.org/10.18632/aging.206325
Image Credits: Copyright: © 2025 Vallejo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).
Keywords: endurance exercise, dietary supplementation, musculoskeletal adaptation, electrocardiogram, aging